Atypical squamous cells are not cancer. Atypical squamous cells reported by cervical liquid-based cytology, or TCT, is not cervical cancer, and can be rechecked at regular intervals, usually 3 to 6 months, and if atypical squamous cells are still present, the extent of cervical inflammation should be further examined. Clinically, atypical squamous cells can also be seen when there is a lesion in the cervix. If inflammation has been ruled out and atypical squamous cells are present on re-examination, colposcopy can be performed to see if the cervical epithelium is diseased. If there are no lesions, regular review is sufficient. Women should have regular TCT and human papillomavirus, or HPV, tests to screen for cervical lesions. Atypical squamous cells are cytologic findings from cervical TCT that require further colposcopic cervical multisite biopsies to be sent for pathologic examination to rule out precancerous cervical lesions and cervical cancer. Atypical squamous cells are not cancerous, but they must be followed up regularly under the guidance of a doctor, and must not be taken lightly, so as not to cause delay in the condition.